Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Radiat Res ; 186(1): 55-64, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27333082

RESUMO

Heart disease is an increasingly recognized, serious late effect of radiation exposure, most notably among breast cancer and Hodgkin's disease survivors, as well as the Hiroshima and Nagasaki atomic bomb survivors. The purpose of this study was to evaluate the late effects of total-body irradiation (TBI) on cardiac morphology, function and selected circulating biomarkers in a well-established nonhuman primate model. For this study we used male rhesus macaques that were exposed to a single total-body dose of ionizing gamma radiation (6.5-8.4 Gy) 5.6-9.7 years earlier at ages ranging from ∼3-10 years old and a cohort of nonirradiated controls. Transthoracic echocardiography was performed annually for 3 years on 20 irradiated and 11 control animals. Myocardium was examined grossly and histologically, and myocardial fibrosis/collagen was assessed microscopically and by morphometric analysis of Masson's trichrome-stained sections. Serum/plasma from 27 irradiated and 13 control animals was evaluated for circulating biomarkers of cardiac damage [N-terminal pro B-type natriuretic protein (nt-proBNP) and troponin-I], inflammation (CRP, IL-6, MCP-1, sICAM) and microbial translocation [LPS-binding protein (LBP) and sCD14]. A higher prevalence of histological myocardial fibrosis was observed in the hearts obtained from the irradiated animals (9/14) relative to controls (0/3) (P = 0.04, χ(2)). Echocardiographically determined left ventricular end diastolic and systolic diameters were significantly smaller in irradiated animals (repeated measures ANOVA, P < 0.001 and P < 0.008, respectively). Histomorphometric analysis of trichrome-stained sections of heart tissue demonstrated ∼14.9 ± 1.4% (mean ± SEM) of myocardial area staining for collagen in irradiated animals compared to 9.1 ± 0.9 % in control animals. Circulating levels of MCP-1 and LBP were significantly higher in irradiated animals (P < 0.05). A high incidence of diabetes in the irradiated animals was associated with higher plasma triglyceride and lower HDLc but did not appear to be associated with cardiovascular phenotypes. These results demonstrate that single total-body doses of 6.5-8.4 Gy produced long-term effects including a high incidence of myocardial fibrosis, reduced left ventricular diameter and elevated systemic inflammation. Additional prospective studies are required to define the time course and mechanisms underlying radiation-induced heart disease in this model.


Assuntos
Raios gama/efeitos adversos , Coração/fisiologia , Coração/efeitos da radiação , Miocárdio/citologia , Irradiação Corporal Total/efeitos adversos , Animais , Biomarcadores/sangue , Peso Corporal/efeitos da radiação , Diabetes Mellitus/metabolismo , Diabetes Mellitus/fisiopatologia , Eletrocardiografia , Coração/fisiopatologia , Lipídeos/sangue , Macaca mulatta , Masculino , Miocárdio/metabolismo , Miocárdio/patologia , Fenótipo , Fatores de Tempo
2.
Proc Natl Acad Sci U S A ; 113(12): 3353-8, 2016 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-26951656

RESUMO

Executive functions including behavioral response inhibition mature after puberty, in tandem with structural changes in the prefrontal cortex. Little is known about how activity of prefrontal neurons relates to this profound cognitive development. To examine this, we tracked neuronal responses of the prefrontal cortex in monkeys as they transitioned from puberty into adulthood and compared activity at different developmental stages. Performance of the antisaccade task greatly improved in this period. Among neural mechanisms that could facilitate it, reduction of stimulus-driven activity, increased saccadic activity, or enhanced representation of the opposing goal location, only the latter was evident in adulthood. Greatly accentuated in adults, this neural correlate of vector inversion may be a prerequisite to the formation of a motor plan to look away from the stimulus. Our results suggest that the prefrontal mechanisms that underlie mature performance on the antisaccade task are more strongly associated with forming an alternative plan of action than with suppressing the neural impact of the prepotent stimulus.


Assuntos
Comportamento Animal , Córtex Pré-Frontal/fisiologia , Maturidade Sexual , Animais , Macaca mulatta , Masculino
3.
Cancer Prev Res (Phila) ; 9(5): 385-95, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-27006379

RESUMO

Endogenous estrogens influence mammary gland development during puberty and breast cancer risk during adulthood. Early-life exposure to dietary or environmental estrogens may alter estrogen-mediated processes. Soy foods contain phytoestrogenic isoflavones (IF), which have mixed estrogen agonist/antagonist properties. Here, we evaluated mammary gland responses over time in pubertal female cynomolgus macaques fed diets containing either casein/lactalbumin (n = 12) or soy protein containing a human-equivalent dose of 120 mg IF/day (n = 17) for approximately 4.5 years spanning menarche. We assessed estrogen receptor (ER) expression and activity, promoter methylation of ERs and their downstream targets, and markers of estrogen metabolism. Expression of ERα and classical ERα response genes (TFF1, PGR, and GREB1) decreased with maturity, independent of diet. A significant inverse correlation was observed between TFF1 mRNA and methylation of CpG sites within the TFF1 promoter. Soy effects included lower ERß expression before menarche and lower mRNA for ERα and GREB1 after menarche. Expression of GATA-3, an epithelial differentiation marker that regulates ERα-mediated transcription, was elevated before menarche and decreased after menarche in soy-fed animals. Soy did not significantly alter expression of other ER activity markers, estrogen-metabolizing enzymes, or promoter methylation for ERs or ER-regulated genes. Our results demonstrate greater ER expression and activity during the pubertal transition, supporting the idea that this life stage is a critical window for phenotypic modulation by estrogenic compounds. Pubertal soy exposure decreases mammary ERα expression after menarche and exerts subtle effects on receptor activity and mammary gland differentiation. Cancer Prev Res; 9(5); 385-95. ©2016 AACR.


Assuntos
Glândulas Mamárias Animais/efeitos dos fármacos , Maturidade Sexual/efeitos dos fármacos , Proteínas de Soja/farmacologia , Animais , Diferenciação Celular/efeitos dos fármacos , Dieta , Feminino , Imuno-Histoquímica , Macaca fascicularis , Glândulas Mamárias Animais/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Fitoestrógenos/farmacologia , Reação em Cadeia da Polimerase , Receptores de Estrogênio , Transcriptoma
4.
Health Phys ; 109(5): 479-92, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26425907

RESUMO

Computed Tomography (CT) and Echocardiography (EC) are two imaging modalities that produce critical longitudinal data that can be analyzed for radiation-induced organ-specific injury to the lung and heart. The Medical Countermeasures Against Radiological Threats (MCART) consortium has a well established animal model research platform that includes nonhuman primate (NHP) models of the acute radiation syndrome and the delayed effects of acute radiation exposure. These models call for a definition of the latency, incidence, severity, duration, and resolution of different organ-specific radiation-induced subsyndromes. The pulmonary subsyndromes and cardiac effects are a pair of interdependent syndromes impacted by exposure to potentially lethal doses of radiation. Establishing a connection between these will reveal important information about their interaction and progression of injury and recovery. Herein, the authors demonstrate the use of CT and EC data in the rhesus macaque models to define delayed organ injury, thereby establishing: a) consistent and reliable methodology to assess radiation-induced damage to the lung and heart; b) an extensive database in normal age-matched NHP for key primary and secondary endpoints; c) identified problematic variables in imaging techniques and proposed solutions to maintain data integrity; and d) initiated longitudinal analysis of potentially lethal radiation-induced damage to the lung and heart.


Assuntos
Ecocardiografia/normas , Traumatismos Cardíacos/diagnóstico , Lesão Pulmonar/diagnóstico , Imagem Multimodal/normas , Lesões por Radiação/diagnóstico , Tomografia Computadorizada por Raios X/normas , Algoritmos , Animais , Guias como Assunto , Estudos Longitudinais , Macaca mulatta , Masculino , Doses de Radiação , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
5.
Proc Natl Acad Sci U S A ; 111(10): 3853-8, 2014 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-24567390

RESUMO

The prefrontal cortex continues to mature after puberty and into early adulthood, mirroring the time course of maturation of cognitive abilities. However, the way in which prefrontal activity changes during peri- and postpubertal cortical maturation is largely unknown. To address this question, we evaluated the developmental stage of peripubertal rhesus monkeys with a series of morphometric, hormonal, and radiographic measures, and conducted behavioral and neurophysiological tests as the monkeys performed working memory tasks. We compared firing rate and the strength of intrinsic functional connectivity between neurons in peripubertal vs. adult monkeys. Notably, analyses of spike train cross-correlations demonstrated that the average magnitude of functional connections measured between neurons was lower overall in the prefrontal cortex of peripubertal monkeys compared with adults. The difference resulted because negative functional connections (indicative of inhibitory interactions) were stronger and more prevalent in peripubertal compared with adult monkeys, whereas the positive connections showed similar distributions in the two groups. Our results identify changes in the intrinsic connectivity of prefrontal neurons, particularly that mediated by inhibition, as a possible substrate for peri- and postpubertal advances in cognitive capacity.


Assuntos
Envelhecimento/fisiologia , Conectoma , Macaca mulatta/fisiologia , Córtex Pré-Frontal/crescimento & desenvolvimento , Potenciais de Ação , Análise de Variância , Animais , Cognição/fisiologia , Masculino , Maturidade Sexual/fisiologia
6.
J Neurophysiol ; 110(11): 2648-60, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24047904

RESUMO

The dorsolateral prefrontal cortex matures late into adolescence or early adulthood. This pattern of maturation mirrors working memory abilities, which continue to improve into adulthood. However, the nature of the changes that prefrontal neuronal activity undergoes during this process is poorly understood. We investigated behavioral performance and neural activity in working memory tasks around the time of puberty, a developmental event associated with the release of sex hormones and significant neurological change. The developmental stages of male rhesus monkeys were evaluated with a series of morphometric, hormonal, and radiographic measures. Peripubertal monkeys were trained to perform an oculomotor delayed response task and a variation of this task involving a distractor stimulus. We found that the peripubertal monkeys tended to abort a relatively large fraction of trials, and these were associated with low levels of task-related neuronal activity. However, for completed trials, accuracy in the delayed saccade task was high and the appearance of a distractor stimulus did not impact performance significantly. In correct trials delay period activity was robust and was not eliminated by the presentation of a distracting stimulus, whereas in trials that resulted in errors the sustained cue-related activity was significantly weaker. Our results show that in peripubertal monkeys the prefrontal cortex is capable of generating robust persistent activity in the delay periods of working memory tasks, although in general it may be more prone to stochastic failure than in adults.


Assuntos
Memória de Curto Prazo , Neurônios/fisiologia , Córtex Pré-Frontal/fisiologia , Maturidade Sexual , Animais , Macaca mulatta , Masculino , Córtex Pré-Frontal/citologia , Córtex Pré-Frontal/crescimento & desenvolvimento , Desempenho Psicomotor , Movimentos Sacádicos
7.
Cancer Prev Res (Phila) ; 6(8): 832-42, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23771522

RESUMO

While epidemiologic studies suggest that soy intake early in life may reduce breast cancer risk, there are also concerns that exposure to soy isoflavones during childhood may alter pubertal development and hormonal profiles. Here, we assessed the effect of a high-soy diet on pubertal breast development, sex hormones, and growth in a nonhuman primate model. Pubertal female cynomolgus monkeys were randomized to receive a diet modeled on a typical North American diet with one of two protein sources for approximately 4.5 years: (i) casein/lactalbumin (CL, n = 12, as control) or (ii) soy protein isolate with a human equivalent dose of 120 mg/d isoflavones (SOY, n = 17), which is comparable to approximately four servings of soy foods. Pubertal exposure to the SOY diet did not alter onset of menarche, indicators of growth and pubertal progression, or circulating estradiol and progesterone concentrations. Greater endometrial area was seen in the SOY group on the first of four postmenarchal ultrasound measurements (P < 0.05). There was a subtle effect of diet on breast differentiation whereby the SOY group showed higher numbers of differentiated large-sized lobular units and a lower proportion with immature ducts following menarche (P < 0.05). Numbers of small lobules and terminal end buds and mammary epithelial cell proliferation did not differ by diet. Expression of progesterone receptor was lower in immature lobules of soy-fed animals (P < 0.05). Our findings suggest that consumption of soy starting before menarche may result in modest effects consistent with a more differentiated breast phenotype in adulthood.


Assuntos
Diferenciação Celular/genética , Dieta , Regulação da Expressão Gênica/efeitos dos fármacos , Glycine max/metabolismo , Isoflavonas/farmacologia , Glândulas Mamárias Animais/citologia , Puberdade/efeitos dos fármacos , Animais , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Feminino , Humanos , Técnicas Imunoenzimáticas , Isoflavonas/sangue , Macaca fascicularis , Glândulas Mamárias Animais/efeitos dos fármacos , Puberdade/fisiologia , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa
8.
Cancer Res ; 72(11): 2833-43, 2012 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22467172

RESUMO

More than 30% of primary prostate cancers contain a consensus deletion of an approximately 800 kb locus on chromosome 6q15.1. The MAP3K7 gene, which encodes TGF-ß activated kinase-1 (Tak1), is a putative prostate tumor suppressor gene within this region whose precise function remains obscure. In this study, we investigated the role of Tak1 in human and murine prostate cancers. In 50 well-characterized human cancer specimens, we found that Tak1 expression was progressively lost with increasing Gleason grade, both within each cancer and across all cancers. In murine prostate stem cells and Tak1-deficient prostatic epithelial cells, Tak1 loss increased proliferation, migration, and invasion. When prostate stem cells attenuated for Tak1 were engrafted with fetal urogenital mesenchyme, the histopathology of the grafts reflected the natural history of prostate cancer leading from prostatic intraepithelial neoplasia to invasive carcinoma. In the grafts containing Tak1-suppressed prostate stem cells, p38 and c-jun-NH(2)-kinase activity was attenuated and proliferation was increased. Together, our findings functionally validate the proposed tumor suppressor role of Tak1 in prostate cancer.


Assuntos
MAP Quinase Quinase Quinases/fisiologia , Neoplasias da Próstata/prevenção & controle , Proteínas Supressoras de Tumor/fisiologia , Animais , Linhagem Celular , Movimento Celular , Proliferação de Células , Humanos , MAP Quinase Quinase Quinases/análise , MAP Quinase Quinase Quinases/antagonistas & inibidores , Masculino , Camundongos , Invasividade Neoplásica , Neoplasias da Próstata/etiologia , Neoplasias da Próstata/patologia
9.
Breast Cancer Res Treat ; 133(2): 617-34, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22037779

RESUMO

Breast cancer (BC) is the most common malignancy of women in the developed world. To better understand its pathogenesis, knowledge of normal breast development is crucial, as BC is the result of disregulation of physiologic processes. The aim of this study was to investigate the impact of reproductive life stages on the transcriptional profile of the mammary gland in a primate model. Comparative transcriptomic analyses were carried out using breast tissues from 28 female cynomolgus macaques (Macaca fascicularis) at the following life stages: prepubertal (n = 5), adolescent (n = 4), adult luteal (n = 5), pregnant (n = 6), lactating (n = 3), and postmenopausal (n = 5). Mammary gland RNA was hybridized to Affymetrix GeneChip(®) Rhesus Macaque Genome Arrays. Differential gene expression was analyzed using ANOVA and cluster analysis. Hierarchical cluster analysis revealed distinct separation of life stage groups. More than 2,225 differentially expressed mRNAs were identified. Gene families or pathways that changed across life stages included those related to estrogen and androgen (ESR1, PGR, TFF1, GREB1, AR, 17HSDB2, 17HSDB7, STS, HSD11B1, AKR1C4), prolactin (PRLR, ELF5, STAT5, CSN1S1), insulin-like growth factor signaling (IGF1, IGFBP1, IGFBP5), extracellular matrix (POSTN, TGFB1, COL5A2, COL12A1, FOXC1, LAMC1, PDGFRA, TGFB2), and differentiation (CD24, CD29, CD44, CD61, ALDH1, BRCA1, FOXA1, POSTN, DICER1, LIG4, KLF4, NOTCH2, RIF1, BMPR1A, TGFB2). Pregnancy and lactation displayed distinct patterns of gene expression. ESR1 and IGF1 were significantly higher in the adolescent compared to the adult animals, whereas differentiation pathways were overrepresented in adult animals and pregnancy-associated life stages. Few individual genes were distinctly different in postmenopausal animals. Our data demonstrate characteristic patterns of gene expression during breast development. Several of the pathways activated during pubertal development have been implicated in cancer development and metastasis, supporting the idea that other developmental markers may have application as biomarkers for BC.


Assuntos
Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/metabolismo , Transcriptoma , Fatores Etários , Animais , Neoplasias da Mama/genética , Matriz Extracelular/metabolismo , Feminino , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Hormônios Esteroides Gonadais/metabolismo , Fator 4 Semelhante a Kruppel , Lactação/genética , Lactação/metabolismo , Macaca fascicularis , Menopausa/genética , Menopausa/metabolismo , Gravidez , Receptores de Esteroides/metabolismo , Maturidade Sexual/genética , Transdução de Sinais
10.
Nature ; 478(7369): 404-7, 2011 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-22012398

RESUMO

Cardiovascular disease remains the leading cause of mortality in westernized countries, despite optimum medical therapy to reduce the levels of low-density lipoprotein (LDL)-associated cholesterol. The pursuit of novel therapies to target the residual risk has focused on raising the levels of high-density lipoprotein (HDL)-associated cholesterol in order to exploit its atheroprotective effects. MicroRNAs (miRNAs) have emerged as important post-transcriptional regulators of lipid metabolism and are thus a new class of target for therapeutic intervention. MicroRNA-33a and microRNA-33b (miR-33a/b) are intronic miRNAs whose encoding regions are embedded in the sterol-response-element-binding protein genes SREBF2 and SREBF1 (refs 3-5), respectively. These miRNAs repress expression of the cholesterol transporter ABCA1, which is a key regulator of HDL biogenesis. Recent studies in mice suggest that antagonizing miR-33a may be an effective strategy for raising plasma HDL levels and providing protection against atherosclerosis; however, extrapolating these findings to humans is complicated by the fact that mice lack miR-33b, which is present only in the SREBF1 gene of medium and large mammals. Here we show in African green monkeys that systemic delivery of an anti-miRNA oligonucleotide that targets both miR-33a and miR-33b increased hepatic expression of ABCA1 and induced a sustained increase in plasma HDL levels over 12 weeks. Notably, miR-33 antagonism in this non-human primate model also increased the expression of miR-33 target genes involved in fatty acid oxidation (CROT, CPT1A, HADHB and PRKAA1) and reduced the expression of genes involved in fatty acid synthesis (SREBF1, FASN, ACLY and ACACA), resulting in a marked suppression of the plasma levels of very-low-density lipoprotein (VLDL)-associated triglycerides, a finding that has not previously been observed in mice. These data establish, in a model that is highly relevant to humans, that pharmacological inhibition of miR-33a and miR-33b is a promising therapeutic strategy to raise plasma HDL and lower VLDL triglyceride levels for the treatment of dyslipidaemias that increase cardiovascular disease risk.


Assuntos
Chlorocebus aethiops , Regulação da Expressão Gênica/efeitos dos fármacos , Lipoproteínas HDL/sangue , Lipoproteínas VLDL/sangue , Fígado/efeitos dos fármacos , MicroRNAs/antagonistas & inibidores , Oligorribonucleotídeos Antissenso/farmacologia , Triglicerídeos/sangue , Transportador 1 de Cassete de Ligação de ATP , Transportadores de Cassetes de Ligação de ATP/metabolismo , Animais , Células Cultivadas , Chlorocebus aethiops/sangue , Chlorocebus aethiops/genética , Chlorocebus aethiops/metabolismo , LDL-Colesterol/sangue , Inativação Gênica , Células HEK293 , Humanos , Fígado/metabolismo , Masculino , MicroRNAs/metabolismo , Fatores de Tempo
11.
Am J Primatol ; 71(9): 802-11, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19484707

RESUMO

Nutritional interventions are important for reducing obesity and related conditions. Soy is a good source of protein and also contains isoflavones that may affect plasma lipids, body weight, and insulin action. Described here are data from a monkey breeding colony in which monkeys were initially fed a standard chow diet that is low fat with protein derived from soy. Monkeys were then randomized to a defined diet with a fat content similar to the typical American diet (TAD) containing either protein derived from soy (TAD soy) or casein-lactalbumin (TAD casein). The colony was followed for over two years to assess body weight, and carbohydrate and lipid measures in adult females (n=19) and their offspring (n=25). Serum isoflavone concentrations were higher with TAD soy than TAD casein, but not as high as when monkey chow was fed. Offspring consuming TAD soy had higher serum isoflavone concentrations than adults consuming TAD soy. Female monkeys consuming TAD soy had better glycemic control, as determined by fructosamine concentrations, but no differences in lipids or body weight compared with those consuming diets with TAD casein. Offspring born to dams consuming TAD soy had similar body weights at birth but over a two-year period weighed significantly less, had significantly lower triglyceride concentrations, and like adult females, had significantly lower fructosamine concentrations compared to TAD casein. Glucose tolerance tests in adult females were not significantly different with diet, but offspring eating TAD soy had increased glucose disappearance with overall lower glucose and insulin responses to the glucose challenge compared with TAD casein. Potential reasons for the additional benefits of TAD soy observed in offspring but not in adults may be related to higher serum isoflavone concentrations in offspring, presence of the diet differences throughout more of their lifespan (including gestation), or different tissue susceptibilities in younger animals.


Assuntos
Peso Corporal/efeitos dos fármacos , Caseínas/farmacologia , Proteínas Alimentares/farmacologia , Glycine max/química , Lactalbumina/farmacologia , Efeitos Tardios da Exposição Pré-Natal/metabolismo , Fatores Etários , Ração Animal/análise , Animais , Feminino , Frutosamina/sangue , Teste de Tolerância a Glucose , Insulina/sangue , Isoflavonas/sangue , Lipídeos/sangue , Macaca fascicularis , Gravidez
12.
Menopause ; 16(3): 466-76, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19265727

RESUMO

OBJECTIVE: The goal of this pilot study was to evaluate the effects of testosterone (T) cotherapy on mammary gland and endometrial measures in a postmenopausal primate model. METHODS: Twenty-five surgically postmenopausal cynomolgus monkeys were randomized by social group to receive daily treatment with (1) placebo, (2) oral micronized 17beta-estradiol (1 mg/d equivalent in women) + progesterone (200 mg/d equivalent in women) (E + P), or (3) E + P with T administered via subcutaneous pellets for 8 weeks at a high dose (15 mg) followed by 8 weeks at a low dose (1.5 mg) (E + P + T). The main outcome measures were breast and endometrial epithelial proliferation, as measured by Ki67/MIB1 immunolabeling. RESULTS: Intralobular breast proliferation did not differ significantly among groups after 8 weeks of treatment but was marginally higher (P = 0.03) in the E + P + T group after 16 weeks of treatment. No significant increase in proliferation was seen for E + P alone. Comparable changes in mammary gland markers of estrogen-receptor activity were seen for the E + P and E + P + T groups. In the endometrium, the addition of T did not increase endometrial glandular proliferation or estrogen-receptor activity or result in any distinct histologic changes. CONCLUSIONS: The findings of this study do not support the idea that T antagonizes the effects of combined hormone therapy on breast proliferation or markers of estrogen-receptor activity. Overall, the short-term effects of T cotherapy on the mammary gland and endometrium were minimal.


Assuntos
Androgênios/administração & dosagem , Endométrio/efeitos dos fármacos , Terapia de Reposição de Estrogênios/efeitos adversos , Glândulas Mamárias Animais/efeitos dos fármacos , Testosterona/administração & dosagem , Administração Oral , Animais , Antagonismo de Drogas , Sistemas de Liberação de Medicamentos , Endométrio/patologia , Estradiol/administração & dosagem , Antagonistas de Estrogênios , Feminino , Macaca fascicularis , Glândulas Mamárias Animais/patologia , Menopausa , Ovariectomia , Progesterona/administração & dosagem , Progesterona/antagonistas & inibidores , Receptores de Estrogênio/análise , Receptores de Estrogênio/efeitos dos fármacos
13.
Clin Vaccine Immunol ; 16(1): 21-8, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18987167

RESUMO

A number of studies have clearly demonstrated that flagellin is a potent adjuvant that promotes robust immune responses when it is given with a protein antigen. In view of the potential biological and practical benefits of a recombinant protein vaccine composed of a single fusion protein containing flagellin and antigen, we have evaluated the efficacy of a fusion protein composed of flagellin and two protective antigens of Yersinia pestis (F1 and V) in eliciting protection against respiratory challenge with Y. pestis. Flagellin-F1-V was produced and purified in high yield under good manufacturing practices conditions. The fusion protein retains full Toll-like receptor 5-stimulating activity in vitro. Using a prime-boost immunization protocol, we found that flagellin-F1-V elicits robust antigen-specific humoral immunity in mice and two species of nonhuman primates. Immune mice were fully protected against intranasal challenge with 150 mean tolerated doses of Y. pestis CO92. In immune mice, the bacteria were completely cleared within 3 days after challenge. Flagellin-F1-V exhibited full stability for at least 297 days at 4 degrees C and at least 168 days at 25 degrees C. At between 29 and 84 days at 37 degrees C, the protein exhibited a loss of biological activity that appeared to be associated with a substantial change in protein diameter, possibly due to oligomerization. On the basis of our results, we believe that flagellin-F1-V is an outstanding candidate for evaluation in studies with humans.


Assuntos
Antígenos de Bactérias/imunologia , Proteínas de Bactérias/imunologia , Flagelina/imunologia , Vacina contra a Peste/imunologia , Proteínas Citotóxicas Formadoras de Poros/imunologia , Animais , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias/genética , Proteínas de Bactérias/genética , Chlorocebus aethiops , Estabilidade de Medicamentos , Armazenamento de Medicamentos , Feminino , Flagelina/genética , Imunização Secundária , Macaca fascicularis , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Vacina contra a Peste/genética , Proteínas Citotóxicas Formadoras de Poros/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Análise de Sobrevida , Temperatura , Fatores de Tempo , Receptor 5 Toll-Like/imunologia , Fatores de Virulência/genética , Fatores de Virulência/imunologia , Yersinia pestis/imunologia
14.
Brain Res ; 1226: 56-60, 2008 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-18619575

RESUMO

Basic data on age-related neuroanatomical changes across the juvenile to adult period in nonhuman primates is sparse, and this gap in knowledge is a serious impediment to translational research aimed at understanding brain development across the lifespan. In this study, magnetic resonance images were analyzed for fifteen mother-reared, socially-housed bonnet macaques (Macaca radiata) in three age groups: juvenile, adolescent, and adult. These data are the first to show age-related changes in gray:white matter ratio and corpus callosum size in bonnet macaques. Juvenile monkeys had higher overall gray:white matter ratio as compared to adolescent and adult monkeys. Corpus callosum (CC) size varied significantly as a function of age and CC region. Total brain volume was significantly lower for juvenile monkeys as compared to both adolescents and adults. These results are consistent in pattern with age-related changes in gray:white matter ratio and regional CC differences observed in humans. Continued study of the animals in this cross-sectional study will provide an important means of determining whether differences observed between age groups reflect developmental differences due to variation in the rate of maturation of CC regions.


Assuntos
Envelhecimento , Encéfalo/anatomia & histologia , Encéfalo/crescimento & desenvolvimento , Macaca radiata/anatomia & histologia , Animais , Corpo Caloso/anatomia & histologia , Corpo Caloso/crescimento & desenvolvimento , Feminino , Imageamento por Ressonância Magnética , Masculino , Neuroanatomia/métodos , Fatores Sexuais
15.
Am J Obstet Gynecol ; 199(2): 158.e1-8, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18501325

RESUMO

OBJECTIVE: The purpose of this study was to assess the effects of lasofoxifene on the reproductive system in ovariectomized nonhuman primates. STUDY DESIGN: This was a 2-year, randomized study. Adult female macaques (Macaca fascicularis) were assigned randomly into 5 groups: ovariectomized, placebo-treated controls (n = 22); sham-ovariectomized, placebo-treated controls (n = 24); ovariectomized animals given 0.021 mg Premarin kg/d (conjugated equine estrogen; n = 25); lasofoxifene at 1.0 mg/kg/d (n = 23); or lasofoxifene at 5.0 mg/kg/d (n = 25). Outcomes included organ weights and histopathologic findings. RESULTS: Lasofoxifene did not increase uterine weight or endometrial thickness and did not change mammary, vaginal, or cervical histologic condition. Mild endometrial fibrosis and cystic change were seen in lasofoxifene-treated animals, in contrast to significant uterine weight increases and endometrial hyperplasia induced by conjugated equine estrogen. CONCLUSION: Lasofoxifene did not increase uterine weight and produced minor histologic uterine changes at the doses that were given and had no effect on the breast, vagina, or cervix.


Assuntos
Mama/efeitos dos fármacos , Pirrolidinas/farmacologia , Tetra-Hidronaftalenos/farmacologia , Útero/efeitos dos fármacos , Vagina/efeitos dos fármacos , Animais , Colo do Útero/efeitos dos fármacos , Endométrio/efeitos dos fármacos , Endométrio/patologia , Feminino , Fibrose , Macaca fascicularis , Tamanho do Órgão/efeitos dos fármacos , Ovariectomia
16.
Stem Cells ; 26(3): 600-10, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18055450

RESUMO

Demonstration of the hallmarks of stem cells, self-renewal and multilineage differentiation, is a challenge that has not been met for numerous tissues postulated to possess adult stem cells, including prostate tissue. Using a defined medium, we reproducibly isolated and maintained adult mouse prostatic cells with characteristics of progenitor/stem cells. Clonal populations of cells demonstrated tissue-specific multilineage differentiation by their ability to generate organized prostatic ductal structures in vivo, with luminal and basal cell layers, when grafted under the renal capsules of mice in the presence of fetal rat urogenital mesenchyme. Complete differentiation was demonstrated by the expression and secretion of terminally differentiated prostatic secretory products into the lumens. Self-renewal was demonstrated by serial transplantation of clonal populations that generated fully differentiated ductal structures in vivo. In vitro, undifferentiated cells expressed markers associated with prostate stem cells, including Sca 1 and CD49f, as well as basal cell markers (p63 and cytokeratins 5 and 14) and, at a low level, luminal cell markers (androgen receptor and cytokeratins 8 and 18). When grafted and allowed to differentiate in the presence of fetal urogenital mesenchyme, the cells differentiated into luminal cells and basal cells with more restricted protein expression patterns. These studies are the first to report a reproducible system to assess adult prostatic progenitor/stem cells.


Assuntos
Diferenciação Celular , Linhagem da Célula , Próstata/citologia , Células-Tronco/citologia , Animais , Ataxina-1 , Ataxinas , Biomarcadores/metabolismo , Proliferação de Células , Células Cultivadas , Células Clonais , Ensaio de Unidades Formadoras de Colônias , Células Epiteliais/citologia , Humanos , Integrina alfa6/metabolismo , Masculino , Camundongos , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Ratos , Recombinação Genética/genética , Regeneração
17.
Psychoneuroendocrinology ; 32(8-10): 981-90, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17768011

RESUMO

The purpose of the experiments reported here was to investigate central nervous system effects of commonly prescribed postmenopausal hormone therapies in a primate model, the cynomolgus monkey (Macaca fascicularis). The results of two experiments are reported. In the first, ovariectomized adult cynomolgus monkeys were treated for eight weeks each with oral micronized 17beta-estradiol (E2) (n=23), E2+medroxyprogesterone acetate (MPA) (n=23), E2+progesterone (P4) (n=23), and placebo (n=23) using a crossover design. In the second, ovariectomized adult cynomolgus monkeys were treated for eight weeks with oral micronized E2+oral micronized P4 (n=10), or E2+intravaginal micronized P4 delivered via a Silastic ring (n=8), or oral placebo and intravaginal placebo (n=5), using a parallel arm design. Behavior was recorded during weeks two through four. Cerebrospinal fluid (CSF) and blood were sampled, and 24h heart rate recorded by telemetry during weeks five through seven. Monoaminergic metabolites were assayed in CSF, and cortisol was assayed in serum. There were no significant effects of treatment on CSF monoaminergic metabolites or heart rate. E2+MPA increased cortisol concentrations. While there were some differences in effects between experiments, both progestogens and both routes of administration increased time spent resting, particularly resting in body contact, resulting in increased passive affiliative interaction. Thus, synthetic progestogens appear to be as sedating as progesterone, and the ring delivery system does not appear to protect the central nervous system from effects of progestogens. Further research is needed to explore social context as an important feature of behavioral response to steroid hormone regimens and to verify and extend knowledge of systemic effects of vaginal ring-delivered progestogens.


Assuntos
Estradiol/administração & dosagem , Terapia de Reposição de Estrogênios , Acetato de Medroxiprogesterona/administração & dosagem , Atividade Motora/efeitos dos fármacos , Pós-Menopausa/efeitos dos fármacos , Progesterona/administração & dosagem , Comportamento Social , Administração Intravaginal , Administração Oral , Agressão/efeitos dos fármacos , Animais , Estudos Cross-Over , Estradiol/sangue , Terapia de Reposição de Estrogênios/veterinária , Feminino , Hidrocortisona/sangue , Dispositivos Intrauterinos Medicados , Macaca fascicularis , Ovariectomia , Placebos , Pós-Menopausa/sangue , Pós-Menopausa/fisiologia , Progesterona/sangue , Distribuição Aleatória
18.
Am J Clin Nutr ; 86(1): 245-50, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17616787

RESUMO

BACKGROUND: Soy consumption is associated with a lower incidence of hip fracture in Asian than in Western women, an effect often attributed to estrogen-like compounds (isoflavones) in soy. It is not known whether premenopausal soy exposure initiated in adulthood can increase bone mass and thereby reduce fracture risk. OBJECTIVE: We aimed to determine whether a high-isoflavone soy diet influences bone mass in soy-naïve, premenopausal cynomolgus monkeys (Macaca fascicularis). DESIGN: Ninety-four skeletally mature females were randomly assigned to consume diets whose protein content came from either high-isoflavone soy or casein and lactalbumin. Animals were socially housed. Bone mass and circulating isoflavone concentrations were measured at baseline and 19 and 31 mo after the start of treatment; bone biomarkers were measured at baseline and 31 mo. RESULTS: There were no significant differences at any timepoint in whole-body bone mineral content between casein-fed (112.5 +/- 2.1, 119.2 +/- 1.9, and 120.7 +/- 2.1 g) and soy-fed (117.2 +/- 2.1, 122.4 +/- 2.0, and 125.4 +/- 2.3 g; P=0.12) monkeys. Similar results were seen for spinal bone mineral density (casein-fed: 0.46 +/- 0.01, 0.50 +/- 0.01, and 0.52 +/- 0.01 g/cm(2); soy-fed: 0.47 +/- 0.01, 0.51 +/- 0.01, and 0.52 +/- 0.01 g/cm(2); P=0.30) and bone biomarker measurements-bone-specific alkaline phosphatase (soy-fed: 82.3 +/- 4.1 and 63.2 +/- 3.4 ng/mL; casein-fed: 94.1 +/- 4.5 and 61.7 +/- 4.3 ng/mL; P=0.22) and C-terminal crosslink of type 1 collagen (soy-fed: 0.944 +/- 0.06 and 0.89 +/- 0.08 nmol/L; casein-fed: 0.97 +/- 0.07 and 0.78 +/- 0.06 nmol/L; P=0.20). CONCLUSION: A soy diet high in isoflavones does not significantly affect bone characteristics in initially soy-naïve premenopausal monkeys.


Assuntos
Densidade Óssea/efeitos dos fármacos , Proteínas Alimentares/administração & dosagem , Isoflavonas/administração & dosagem , Macaca fascicularis/metabolismo , Proteínas de Soja/administração & dosagem , Absorciometria de Fóton , Fosfatase Alcalina/sangue , Animais , Densidade Óssea/fisiologia , Caseínas/administração & dosagem , Colágeno Tipo I/sangue , Feminino , Isoflavonas/sangue , Lactalbumina/administração & dosagem , Vértebras Lombares/fisiologia , Peptídeos/sangue , Distribuição Aleatória , Comportamento Social
19.
Am J Obstet Gynecol ; 196(1): 75.e1-7, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17240242

RESUMO

OBJECTIVE: Assess effects of 2 novel selective estrogen receptor modulators on the reproductive system. STUDY DESIGN: Adult, ovariectomized, female Macaca fascicularis, n = 3 per group, orally dosed for 12 weeks with vehicle; selective estrogen receptor modulator 393 (2, 4, or 8 mg/kg/day); selective estrogen receptor modulator 379 (4 mg/kg per day); raloxifene (3 mg/kg per day); tamoxifen (1 mg/kg per day); or ethinyl estradiol (3 microg/kg per day). Outcomes included organ weights, histopathology, plasma lipids, and bone biomarkers. RESULTS: Novel selective estrogen receptor modulators tested did not alter uterine weight or endometrial histology. Tamoxifen and ethinyl estradiol increased uterine weight 2- to 3-fold (P <.05) and endometrial glandular proliferation 5- to 6-fold (P < .05). Adrenal weight was 50% higher in the tamoxifen group. Ethinyl estradiol increased breast lobular epithelial proliferation 6-fold (P < .05). Selective estrogen receptor modulators 393 and ethinyl estradiol decreased bone biomarkers. CONCLUSION: The results for raloxifene, tamoxifen, and ethinyl estradiol are consistent with previous findings, and results for selective estrogen receptor modulator 393 and selective estrogen receptor modulator 379 indicate potential for tissue selectivity.


Assuntos
Estrogênios/farmacologia , Etinilestradiol/farmacologia , Glândulas Mamárias Animais/efeitos dos fármacos , Ovariectomia , Cloridrato de Raloxifeno/farmacologia , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Tamoxifeno/farmacologia , Útero/efeitos dos fármacos , Vagina/efeitos dos fármacos , Animais , Feminino , Macaca fascicularis , Glândulas Mamárias Animais/patologia , Útero/patologia , Vagina/patologia
20.
Menopause ; 14(4): 639-47, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17224855

RESUMO

OBJECTIVE: To evaluate the effects of oral estradiol given with either oral or intravaginal micronized progesterone (P4) on risk biomarkers for breast cancer in a postmenopausal monkey model. DESIGN: This experiment was a two-way crossover study in which 20 ovariectomized adult female cynomolgus macaques were treated (in equivalent doses for women) with oral estradiol (1 mg/d) + oral micronized P4 (200 mg/d) or intravaginal P4 delivered by Silastic rings (6- to 10-mg/d release rate). Hormone treatments lasted 2 months and were separated by a 1-month washout period. The primary outcome measure was breast epithelial proliferation. RESULTS: Serum P4 concentrations were significantly greater in subjects receiving oral P4 (10.9 ng/mL) compared with intravaginal P4 (3.8 ng/mL) at 2 to 3 hours after oral dosing (P<0.0001) but not at 24 to 28 hours after oral dosing (2.9 ng/mL for oral P4 vs 3.2 ng/mL for intravaginal P4 at 2 months, P=0.19). Serum estradiol concentrations were significantly lower after oral P4 than after intravaginal P4 (P<0.05 for all time points). Oral P4 resulted in significantly decreased body weight (-2.5%) compared with intravaginal P4 (+3.6%) (P=0.0001). Markers of breast proliferation, sex steroid receptor expression, and endometrial area did not differ significantly between oral P4 and intravaginal P4 treatments (P>0.1 for all). CONCLUSIONS: Despite different pharmacodynamic profiles, oral and intravaginal P4 had similar effects on biomarkers in the postmenopausal breast.


Assuntos
Mama/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Modelos Animais de Doenças , Estradiol/farmacologia , Macaca fascicularis , Progesterona/farmacologia , Administração Intravaginal , Administração Oral , Animais , Biomarcadores Tumorais/metabolismo , Mama/citologia , Neoplasias da Mama/induzido quimicamente , Neoplasias da Mama/metabolismo , Estudos Cross-Over , Células Epiteliais/citologia , Células Epiteliais/efeitos dos fármacos , Estradiol/administração & dosagem , Terapia de Reposição de Estrogênios/efeitos adversos , Feminino , Ovariectomia , Pós-Menopausa , Progesterona/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...